2018
DOI: 10.4103/jco.jco_8_18
|View full text |Cite
|
Sign up to set email alerts
|

Intensified versus non-intensified induction therapy with cytarabine and daunorubicin for patients with newly diagnosed acute myeloid leukemia

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles